Twist Bioscience Corporation
TWST
Peringkat dalam Saham
#2142
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Harga Saham
$144.87
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$9.54B
Perubahan (1 hari)
3.65%
Perubahan (1 tahun)
333.86%
Negara
US
Perdagangan Twist Bioscience Corporation (TWST)
Kategori
Healthcare
Rasio P/E untuk Twist Bioscience Corporation (TWST)
Rasio P/E per October 2026 TTM: -66.74
Menurut laporan keuangan dan harga saham terbaru dari Twist Bioscience Corporation, rasio P/E saat ini (TTM) adalah -66.74. Pada akhir 2024, perusahaan memiliki rasio P/E sebesar -12.56.
Riwayat rasio P/E untuk Twist Bioscience Corporation dari 2016 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | -66.74 | 207.98% |
| 2025 | -21.67 | 72.55% |
| 2024 | -12.56 | 122.96% |
| 2023 | -5.63 | -35.38% |
| 2022 | -8.72 | -74.32% |
| 2021 | -33.93 | 59.49% |
| 2020 | -21.28 | 249.33% |
| 2019 | -6.09 | 16.47% |
| 2018 | -5.23 | 17.97% |
| 2017 | -4.43 | -25.66% |
| 2016 | -5.96 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 36.15 | -154.17% |
US
|
|
| 39.77 | -159.60% |
US
|
|
| -290.26 | 334.92% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -151.22% |
US
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.